Clinical Researcher—January 2019 (Volume 33, Issue 1) PEER REVIEWED Takoda H. Roland, CCRP, CCRA, CNA       The clinical research organization (CRO) I work for doesn’t provide source documentation for studies, so every site we work with does things a bit differently. The variations in source data formats and quality create inconsistencies in data capture and increase the monitoring burden by forcing the clinical research associate (CRA) for any given multisite study to learn how each site operates. Even for a small Phase III trial with only about 50 research sites in the U.S. and Canada, the hassles to a monitor of conducting visits and capturing data that are collected according to myriad site-specific standard operating procedures can be overwhelming. Phase III studies are sophisticated operations and are increasing in complexity,{1} so the chances that 50 different sites perfectly capture all the data we need are close to zero. … Continue reading Opinion: A Futurist View on the Use of Technology in Clinical Trials